<DOC>
	<DOCNO>NCT00811525</DOCNO>
	<brief_summary>The Contour Profile Gel Continued Access Study design demonstrate safety Mentor 's Mammary Prostheses woman undergo primary augmentation , primary reconstruction , revision . Safety information rate capsular contracture , rupture , infection collect , use help determine device safety . With approval MemoryShape™ Medium Height , Moderate Profile ( CPG 321 ) Breast Implants June 14 , 2013 , CPG CA Study subject enrollment close study convert post approval study style .</brief_summary>
	<brief_title>Post Approval Continued Access Study MENTOR® Contour Profile Gel Breast Implant</brief_title>
	<detailed_description>Silicone gel-filled breast implant introduce early sixty wide-scale distribution time Medical Device Amendments Food Drug Cosmetic Act pass 1976 . In 1983 , gel-filled breast implant designate Class III device require premarket approval . In May 1990 , Food Drug Administration ( FDA ) publish propose request ( 515 ( b ) ) Premarket Approval Applications ( PMA ) April 1991 publish final request . This final publication put manufacturer gel-filled breast implant notice continue market gel-filled breast implant , PMA due FDA 90 day final publication date . A premarket approval ( PMA ) Mentor gel-filled breast implant file FDA July 1991 . At FDA General Plastic Surgery Advisory Committee meet November 1991 , committee recommend submission additional information establish safety effectiveness gel-filled breast implant . In January 1992 , FDA Commissioner announce voluntary moratorium sale gel-filled breast implant allow advisory panel time assess additional information . In April 1992 , moratorium lift reconstruction revision patient . Every patient implant part adjunct study , offer participation registry gel-filled breast implant patient . In order implant gel-filled implant augmentation , woman enrol core clinical study . In September 2000 Core Gel study begin , lead way November 2006 FDA approval Core Gel implant Memory Gel breast implant . The objective Contour Profile Gel Continued Access determine safety Silicone Contour Profile Gel Mammary Prostheses woman undergo primary breast augmentation , primary breast reconstruction , revision . While Core CPG patient follow-up complete , Continued Access Study design enroll patient limited rate per month allow continued physician experience device collect additional safety data support future PMA . Safety data collect submitted supplemental data . The CPG-CA study include original investigator surgical site Core CPG study . However , original Core CPG investigator CPG-CA study . Throughout duration study , patient require follow-up visit 10 week post-surgery every year surgery 10th year completion Core CPG study . ( This follow-up requirement change 10 year 5 year upon device approval ) . Unlike Core CPG study , CPG-CA study randomize selection MRI patient require component study . On June 14 , 2013 , FDA approve Mentor® MemoryShape™ Breast Implants ( CPG Style 321 Medium Height , Moderate Profile ) follow indication : - Breast Augmentation woman least 22 year old . - Breast Reconstruction .</detailed_description>
	<criteria>Subject Genetic female least 18 year old A candidate : Primary breast augmentation ( general breast enlargement ) Primary breast reconstruction ( cancer , trauma , surgical loss breast congenital deformity ) Revision surgery ( previous augmentation reconstruction siliconefilled salinefilled implant ) Signs Informed Consent Agrees return device Mentor device explanted Agrees comply followup procedure , include return followup visit Subject pregnant Has nurse child within three month study enrollment Been implant silicone implant breast implant Confirmed diagnosis rheumatic disease Currently condition could compromise complicate wound heal ( except reconstruction subject ) Subject Augmentation cohort diagnosis active cancer type , except lowgrade nonmetastasizing skin cancer Infection abscess anywhere body Demonstrates tissue characteristic clinically incompatible implant ( e.g . tissue damage result radiation , inadequate tissue , compromise vascularity ) Possesses condition , treatment condition , opinion investigator and/or consult physician ( ) , may constitute unwarranted surgical risk . Anatomic physiologic abnormality could lead significant postoperative adverse event Demonstrates characteristic unrealistic/unreasonable risk involve surgical procedure Premalignant breast disease without subcutaneous mastectomy . Untreated inappropriately treat breast malignancy , without mastectomy Are HIV positive Work Mentor study doctor directlyrelated anyone work Mentor study doctor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Breast Augmentation</keyword>
	<keyword>Breast Reconstruction</keyword>
	<keyword>Breast Revision</keyword>
	<keyword>Silicone gel</keyword>
	<keyword>Contour Profile Gel</keyword>
	<keyword>Siltex</keyword>
</DOC>